FDA.reportPublic FDA data

Xeljanz 1 MG/ML Oral Solution

RxCUI
2478437
RxNorm name
Xeljanz 1 MG/ML Oral Solution
Display name
Xeljanz 1 MG/ML Oral Solution
Full name
Xeljanz 1 MG/ML Oral Solution
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:22

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
cf74ba2f-afc5-4baa-8594-979c889a5831Xeljanz 1 MG/mL Oral Solution [PSN] · tofacitinib 1 MG/ML Oral Solution [Xeljanz] [SBD] · Xeljanz 1 MG/ML Oral Solution [SY]353These highlights do not include all the information needed to use XELJANZ/XELJANZ XR safely and effectively. See full prescribing information for XELJANZ/XELJANZ XR. XELJANZ ® (tofacitinib) tablets, for oral use XELJANZ ® (tofacitinib) oral solution XELJANZ ® XR (tofacitinib) extended-release tablets, for oral use Initial U.S. Approval: 201220260312
68e3d6b2-7838-4d2d-a417-09d919b43e13Xeljanz 1 MG/mL Oral Solution [PSN] · tofacitinib 1 MG/ML Oral Solution [Xeljanz] [SBD] · Xeljanz 1 MG/ML Oral Solution [SY]317These highlights do not include all the information needed to use XELJANZ/XELJANZ XR safely and effectively. See full prescribing information for XELJANZ/XELJANZ XR. XELJANZ ® (tofacitinib) tablets, for oral use XELJANZ ® (tofacitinib) oral solution XELJANZ ® XR (tofacitinib) extended-release tablets, for oral use Initial U.S. Approval: 201220260327